ABOUT
Nominating Committee
Responsibilities
Laura J. Tafe, MD (Chair) Dartmouth Hitchcock Medical Center
The AMP Nominating Committee is composed of the Past President (Chair) and two representatives from each subdivision. The chair and subdivision representatives are primarily responsible for recruiting qualified AMP members to run for elected offices. A ballot is compiled and made available for voting by all current Regular AMP members. Voting for elected offices usually takes place during the month of May each year.
Please consider nominating a colleague for elected office. In addition, self-nominations are encouraged. Click here to read descriptions for all elected positions. Interested? Please contact a Nominating Committee member.
Committee Members - 2024
If you are interested in serving on the Nominating Committee, please see the various roles available and the responsibilities of each role by clicking here.
Chair
Laura J. Tafe, MD
Dartmouth Hitchcock Medical Center
Genetics Subdivision Representative (2023-2024)
Tina Hambuch Hawks, PhD
Quest Diagnostics
Genetics Subdivision Representative (2024-2025)
Jane Houldsworth, PhD
Icahn School of Medicine at Mount Sinai, Mount Sinai Health System
Hematopathology Subdivision Representative (2023-2024)
Mark D. Ewalt, MD
Memorial Sloan Kettering Cancer Center
Hematopathology Subdivision Representative (2024-2025)
Valentina Nardi, MD
Massachusetts General Hospital and Brigham and Women’s Hospital
Infectious Diseases Subdivision Representative (2023-2024)
Ana María Cárdenas, PhD
Becton, Dickinson, and Company (BD)
Infectious Diseases Subdivision Representative (2024-2025)
Morgan A. Pence, PhD
Cook Children’s Medical Center
Informatics Subdivision Representative (2023-2024)
Ahmet Zehir, PhD
AstraZeneca
Informatics Subdivision Representative (2024-2025)
Jing Xu, MD, PhD
UT Southwestern Medical Center
Solid Tumors Subdivision Representative (2023-2024)
Nikoletta Sidiropoulos, MD
University of Vermont Medical Center
Solid Tumors Subdivision Representative (2024-2025)
Jaclyn F. Hechtman, MD
Miami Cancer Institute, Baptist Health South Florida and Neogenomics Laboratories
Ex Officio Committee Members
President
Maria E. Arcila, MD
Memorial Sloan Kettering Cancer Center
Chief Executive Officer
Laurie S. Menser, CAE
